These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 16342903)
1. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents. Kimura J; Ishiguchi T; Matsuda J; Ohno R; Nakamura A; Kamei S; Ohno K; Kawamura T; Murata K Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513 [TBL] [Abstract][Full Text] [Related]
3. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Puttagunta NR; Gibby WA; Smith GT Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874 [TBL] [Abstract][Full Text] [Related]
4. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery]. Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine. Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243 [TBL] [Abstract][Full Text] [Related]
6. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497 [TBL] [Abstract][Full Text] [Related]
7. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333 [TBL] [Abstract][Full Text] [Related]
8. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging. Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557 [TBL] [Abstract][Full Text] [Related]
9. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821 [TBL] [Abstract][Full Text] [Related]
10. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine. Bauner KU; Reiser MF; Huber AM Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911 [TBL] [Abstract][Full Text] [Related]
11. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents. Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904 [TBL] [Abstract][Full Text] [Related]
12. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver]. Zhang HM; Ouyang H; Zhou CW Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014 [TBL] [Abstract][Full Text] [Related]
14. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators. Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277 [TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels and clinical symptoms following gadolinium administration in hemodialysis patients. Schieren G; Tokmak F; Lefringhausen L; van Bracht M; Perings C; Willers R; Günsel A; Kemper F; Wiesmüller GA; Rump LC Am J Kidney Dis; 2008 Jun; 51(6):976-86. PubMed ID: 18501785 [TBL] [Abstract][Full Text] [Related]
17. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice. Ye J; Xu YK; Liu X; Lü GS Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging. Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081 [TBL] [Abstract][Full Text] [Related]
19. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights. Cheng HL; Wallis C; Shou Z; Farhat WA J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model. Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]